INFORMED.
LIVE

Anthem Biosciences Limited

BSE: ANTHEM544449ISIN INE0CZ201020
  • Healthcare
  • Biotechnology
  • BSE 500

Share price

₹887.45+32.95 (+3.86%)
as of 4 Nov 2026
Anthem Biosciences Limited share price, 4 Nov 2025 to 4 Nov 2026: ₹702.50 to ₹887.45 (+26.3%). Low ₹592.05, high ₹957.80. Volume shown below the price.

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high
₹977.00
52W low
₹579.45
Off 52W high
-9.17%
1M return
+4.17%
3M return
+7.47%
6M return
+15.49%
1Y return
+26.33%
20D avg volume
2,53,914
50 DMA
₹880.86
200 DMA
₹769.89

Key ratios Consolidated

Market cap
₹50,022 Cr
Current price
₹887.45
52W high / low
₹977.00 / ₹579.45
Face value
₹2.00
P/E
81.45
P/B
15.24
EPS (TTM)
₹10.90
Book value / share
₹58.22
ROE
—
ROCE
26.80%
Operating margin
—
Net margin
—
Debt / equity
0.02
Net debt
₹-221.85 Cr
Interest cover
120.63
Dividend yield
0.23%
Dividend / share (TTM)
₹2.00
Payout
18.35%
Cash conversion cycle
110.0 days

Financials

MetricQ2 FY27Q1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25
Income statement
594.03418.22610.94423.15550.03540.21—
58.9024.8951.2133.5348.2322.81—
652.93443.11662.15456.68598.26563.02—
356.56298.53385.22300.84368.65376.77—
200.77148.56165.20184.92201.26162.21—
0.000.000.000.000.000.00—
81.2578.8472.4870.4867.7272.03—
3.310.891.900.353.031.61—
30.7129.9939.5934.5333.5026.45—
56.6042.6255.7952.8841.0545.81—
296.37144.58276.94155.84229.60186.25—
0.000.000.98-25.370.000.00—
296.37144.58277.92130.47229.60186.25—
84.9124.6488.1637.6656.1750.46—
211.46119.94189.7692.82173.43135.79—
3.752.136.761.653.092.43—
Key metrics
330.39175.46319.41165.35266.13214.31—
55.60%42.00%52.30%39.10%48.40%39.70%—
35.60%28.70%31.10%21.90%31.50%25.10%—
9.00%—9.00%—8.20%——
8.00%-22.60%—————
21.90%-11.70%—————
MetricTTMFY26FY25
Income statement
2,0462,124—
168.53155.78—
2,2152,280—
1,3411,431—
699.45713.59—
0.000.00—
303.05282.70—
6.456.89—
134.82134.07—
207.89195.53—
873.73848.63—
-24.39-24.39—
849.34824.24—
235.37232.45—
613.98591.79—
14.2921.10—
Key metrics
990.61965.20—
48.41%45.40%—
30.00%27.90%—
—26.80%—
—633.32—
—1.43—
—0.02—
—-221.85—
—110.0—
Balance sheet
—3,429—
—1,803—
—272.91—
—590.59—
—124.52—
—147.28—
—780.26—
—75.22—
—325.71—
—51.06—
—23.33—
—27.73—
—3,043—
Cash flow
—844.49—
—-701.62—
—-40.00—
—211.17—
MetricQ2 FY27Q1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25
Income statement
572.11383.84582.50416.57552.23538.01—
64.6928.6060.6239.9253.8027.73—
636.80412.44643.13456.50606.02565.74—
332.69276.08343.38281.40352.72366.80—
193.44144.94150.07180.57203.71162.40—
0.000.000.000.000.000.00—
74.3072.7866.7265.4763.1668.57—
3.060.761.581.132.231.61—
22.2122.3126.2826.7523.9222.61—
50.6237.6548.4649.8237.6042.95—
304.12136.36299.75175.09253.30198.94—
0.000.000.97-24.980.000.00—
304.12136.36300.72150.11253.30198.94—
83.2334.3589.0637.9854.8750.60—
220.89102.01211.66112.12198.43148.34—
3.921.813.772.003.542.65—
Key metrics
329.39159.43328.58177.99279.45223.16—
57.60%41.50%56.40%42.70%50.60%41.50%—
38.60%26.60%36.30%26.90%35.90%27.60%—
8.80%—9.30%—8.70%——
3.60%-28.70%—————
11.30%-31.20%—————
MetricTTMFY26FY25
Income statement
1,9552,089—
193.83182.07—
2,1492,271—
1,2341,344—
669.02696.75—
0.000.00—
279.27263.92—
6.536.55—
97.5599.56—
186.55178.83—
915.32927.08—
-24.01-24.01—
891.31903.07—
244.62232.51—
646.68670.56—
11.5011.95—
Key metrics
995.391,009—
50.91%48.30%—
33.08%32.10%—
—28.00%—
—749.43—
—1.33—
—0.01—
—-220.71—
—108.6—
Balance sheet
—3,531—
—1,688—
—267.88—
—572.93—
—119.14—
—63.62—
—609.60—
—70.34—
—285.47—
—47.17—
—18.97—
—28.20—
—3,185—
Cash flow
—889.41—
—-742.00—
—-43.55—
—139.98—

Compounded growth

Standalone

Sales CAGR 3Y
—
Sales CAGR 5Y
—
Profit CAGR 3Y
—
Profit CAGR 5Y
—
Sales YoY (TTM)
—
Profit YoY (TTM)
—

Consolidated

Sales CAGR 3Y
—
Sales CAGR 5Y
—
Profit CAGR 3Y
—
Profit CAGR 5Y
—
Sales YoY (TTM)
—
Profit YoY (TTM)
—

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding
71.39%
QuarterSeptember 2026June 2026
Promoter %71.39%71.42%
HolderTypeHoldingPreviousChange
AJAY BHARDWAJPromoter42.39%42.40%-0.01%
ISHAAN BHARDWAJPromoter10.12%10.13%-0.01%
GANESH SAMBASIVAMPromoter8.10%8.11%-0.01%
K C RAVINDRAPromoter7.75%7.75%0.00%
PORTSMOUTH TECHNOLOGIES LLCPublic2.73%2.73%0.00%
SATISH S SHARMAPublic2.26%2.26%0.00%
MALAY JIBAN BARUAPublic2.26%2.26%0.00%
RUPESH NARHARRAO KINEKARPublic2.26%2.21%+0.05%
HDFC MUTUAL FUND - HDFC BUSINESS CYCLE FUNDPublic1.90%——
SBI MNC FUNDPublic1.75%1.76%-0.01%
AXIS ELSS TAX SAVER FUNDPublic1.36%1.19%+0.17%
S VIJAYALAKSHMIPromoter Group1.01%1.01%0.00%
SWARA TRUST(Trustee is K C RAVINDRA)Promoter Group1.01%1.01%0.00%
KEERTHI TRUST(Trustee is K C RAVINDRA)Promoter Group1.01%1.01%0.00%
KC NIRMALAPromoter Group0.00%0.00%0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

CompanyMkt cap (₹ Cr)Price (₹)P/EROCESales YoYProfit YoY1Y return
Anthem Biosciences Limited50,022887.4581.4526.80%——+26.33%
Advanced Enzyme Technologies Limited3,121278.7017.3913.60%+10.31% TTM+18.17% TTM-11.17%
Ennature Bio Pharma Limited584261.25—————
CCME GLOBAL LIMITED S16335.93-189.11-1.80%—-124.71% TTM-78.98%
Vivo Bio tech Ltd.3113.88-10.787.20%+12.33% TTM-133.73% TTM-56.96%
Shree Ganesh Biotech (India) Limited S180.44-44.000.80%-77.47% TTM-400.00% TTM-39.73%
GENOMIC VALLEY BIOTECH LIMITED S1755.67-5,567.001.00%-80.30% TTM-110.00% TTM+56.46%

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Final Dividend - Rs. - 2.000025 Jun 202626 Jun 2026—

Board meetings

  • Board Meeting - Financial Results
  • Board Meeting - Financial Results